Navigation Links
Cheaper and Quicker Alternative to Ovarian Reserve Tests

Researchers from Netherlands say that simple transvaginal ultrasound scans can do away with invasive, expensive and time consuming hormone- based tests, used for determining// a woman’s success rate in IVF programs.

The researchers led by Janet Kwee from Vrije Universiteit Medical Center in Amsterdam carried out ultrasound tests on the ovaries of women subjects in an IVF program.

IVF or in vitro fertilization in layman’s terms means the fertilization of sperms and eggs outside their natural settings.

Maximum number of follicles is stimulated to grow in a woman’s ovaries with the help of extra hormones and these are then ‘harvested’ for their subsequent fertilization with sperms.

Fertilization will be carried out in lab dishes before the embryos are implanted in the uterus.

As IVF is a substantially expensive option of assisted reproduction, a woman’s chance of success for IVF is determined beforehand, in order to advice for or against IVF.

Determining the chance of developing sufficient quantity and quality of the eggs by ovarian reserve tests or hormone tests does this. It is in this context that Kwee and team claim significance for their study findings.

The researchers studied 110 women aged 18-39 who had difficulty conceiving.

Kwee counted the number of antral follicles, small egg-bearing ovarian follicles about 2-10 mm in diameter, with transvaginal sonography (ultrasound).

Kwee compared the follicle count with ovarian volume with the results from ovarian reserve endocrine tests.

It was seen that the antral follicle count was an effective predictor of the number of eggs the patient would ultimately produce when her ovaries had been stimulated during IVF treatment.

Says Kwee, “The follicle count is just as good a test for ovarian response as expensive and time consuming endocrine tests."

The count appears to be "the only test able t
'"/>




Page: 1 2

Related medicine news :

1. Cipro Has Cheaper Cousins to Treat Anthrax
2. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
3. Cheaper Vaccines From Tomatoes To Fight HIV, Hepatitis B
4. Diabetics to get Relief from Cheaper Drugs
5. Quicker healing with active bandages
6. Energy Therapy For Quicker Healing
7. Prince Charles lends support to Alternative Medicine
8. Alternative medicine more popular among HIV positive patients
9. Complementary and Alternative medicine
10. Alternative therapies popular with Parkinsons patients
11. Alternative to blood Transfusions
Post Your Comments:
(Date:7/23/2008)...to Meet the Financing Needs of European and ...-, NEW YORK, July 24 /PRNewswire/ -- Paul Capital... has been promoted to Partner. Based in Paul,Capit... sourcing,evaluating and negotiating European and... Paul Capital Healthcare funds., "Since he joined...
(Date:7/23/2008)... /PRNewswire/ -- MediVoice(R), LLC, the,world,s fi...and,e-Prescribing, has formed a strategic partners...ractive, web-based, patient-centered health record...integrate and market its,mobile voice-activation s...) system., "MediVoice is pleased to develop a str...
(Date:7/23/2008)...wire/ -- Philip J. Dwyer, president and CEO,of the... before the U.S.,Senate Health, Education, Labor, ...nd Families today to call for increased funds for ...ed at YMCAs across the nation, that will,help redu...on behalf of the more than 2,600 YMCAs, that -- fo...
(Date:7/23/2008)...gration and Naturalization ready at Passport ...y 23 /PRNewswire/ -- New vaccine requirements will...sa for entry into the U.S. and,anyone seeking adju...ts,must show proof of vaccinations against vaccine...Advisory Committee on Immunization Practices.,Pass...
Breaking Medicine News(10 mins):Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 2Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 3Health News:USCIS Tightens Vaccination Requirements 2
... Health says many smokers are yet to understand th...warning pictures are an effective// way to get the...r of Health, Damien O'Connor, today launched a pro...ackets. The Ministry wants feedback on whether he...
...ol of Business (ISB) Tuesday signed a memorandum o...derabad-based real estate company, to establish// ...n studies'. This is said to be the first such st...chool in India. It is also the first research cha...
... found a gene that increased Type 2 diabetes in ov...d new treatment for the condition in humans. // T...ition, with an estimated 16 million Americans affl...en, the development of the disease is caused by ob...
...high on fiber is perhaps the first thing that doct...offsetting hemorrhoids. // Hemorrhoids, a conditio...n and around the anus that can give rise to bleedi...erican Society of Colon and Rectal Surgeons, hemor...
Other Medicine News:Health News:New Zealand To Issue Graphic Warnings In Cigarette Packs 2
(Date:7/23/2008)...apy to Treat the Disease -, WAYNE, N.J. and EMERY...ayer HealthCare Pharmaceuticals and Onyx Pharmaceu...he New England Journal of Medicine published,resul...) (sorafenib),tablets decreased the absolute risk ...le hepatocellular carcinoma (HCC), or liver cancer...
(Date:7/23/2008)...e/ -- The following was,released by the U.S. Depar...er Smith, and Members of the Committee.,Thank you ...peared before this Committee almost six months ago...lented and dedicated professionals,at the Justice ...ome to,appreciate that much more deeply their serv...
(Date:7/23/2008)...Code BioPharmaceutics, Inc.,an emerging biopharma...,results demonstrating the utility of their lead d...chronic blood disorder paroxysmal nocturnal,hemogl...nted at the XXII,International Complement Workshop...only treatment currently available for PNH patient...
(Date:7/22/2008)...FirstCall/ -- Following a,thorough review that con...euticals Limited (ASX: PGL; Nasdaq: PGLA) today an... study in liver cancer. Progen confirmed,its strat...f compounds and,the company will actively seek to ...ough Merger & Acquisition activity., The strategi...
Breaking Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3New Lung Association Study Shows 24142 Billion Benefit of Converting to Zero Emission Vehicles by 2030 14836 1New Lung Association Study Shows 24142 Billion Benefit of Converting to Zero Emission Vehicles by 2030 14836 2New Lung Association Study Shows 24142 Billion Benefit of Converting to Zero Emission Vehicles by 2030 14836 3New Lung Association Study Shows 24142 Billion Benefit of Converting to Zero Emission Vehicles by 2030 14836 4NHS Choices Launches New Fitness Section 14834 1Admins Support 65 25 More Pharma Operations Execs than Rule of Thumb Dictates 14832 1Admins Support 65 25 More Pharma Operations Execs than Rule of Thumb Dictates 14832 2Monkey Brain Gives Clues to Human Interaction 14831 1Monkey Brain Gives Clues to Human Interaction 14831 2
.../PRNewswire/ -- Novagali Pharma, an,emerging ophth...lmology, announces today positive results from the...n suffering from Vernal,Keratoconjunctivitis (VKC)...ymptoms and signs of disease improved in patients,...y to Vekacia(R),was excellent. , VKC is a severe f...
...Apr 4, 2007 - CytRx Corporation,(NASDAQ:CYTR) toda...stroke studies indicating that CytRx,s lead drug c... recovery of sensory and,motor function in an expe...was withheld as long as 48 hours after stroke was,...nical data,announced by CytRx in December 2006. Or...
Other Medicine Technology:Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 2CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 3CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 4CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 5
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations.
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations.
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations.
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations.
Medicine Products: